Dr. Howard Fillit: The Future of Precision Medicine in Alzheimer’s Disease Treatment
Description
Precision medicine is a medical approach that considers a patient’s genes, environment, and lifestyle. In the realm of Alzheimer’s disease, experts are pushing for using this approach to improve diagnosis, treatment, and our understanding of the condition.
But what does precision medicine for patients with Alzheimer’s disease and other dementias look like?
The Alzheimer’s Drug Discovery Foundation (ADDF)’s Dr. Howard Fillit joins Being Patient Live Talks to discuss precision medicine and its potential in Alzheimer’s diagnosis and care.
Fillit is an award-winning geriatrician, neuroscientist, and innovative philanthropy executive who has led the ADDF since its founding. He has authored or co-authored over 300 publications and is the senior editor of Brocklehurst’s Textbook of Geriatric Medicine and Gerontology. He has held faculty positions at Rockefeller University, the SUNY-Stony Brook School of Medicine, and the Cornell University School of Medicine. Fillit also maintains a limited private practice in consultative geriatric medicine focusing on Alzheimer’s disease and related dementias.
United States
